CLRN1-AS1

Across TCGA pan-cancer cohorts, CLRN1-AS1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CLRN1-AS1 data layer compared with 22 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher CLRN1-AS1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CLRN1-AS1 expression acts as an unfavorable survival marker.

UCEC and ESCA are the cancer types where CLRN1-AS1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	All	0.661	0.928	.020	16	view →
ESCA	OS	Median	All	0.455	0.703	.018	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

CLRN1-AS1–UCEC (OS)

Open the UCEC breakdown →